Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 13393

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : May | Volume : 18 | Issue : 5 | Page : RC01 - RC05 Full Version

Microbiological Evaluation of Paediatric Chronic Haematogenous Osteomyelitis in a Tertiary Care Hospital in Northern India and its Association with Radiological Appearance: A Retrospective Study


Published: May 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/64451.19359
Chetan Peshin, Rohan Ratra, Anil Juyal

1. Professor, Department of Orthopaedics, Himaliyan Institute of Medical Sciences, Dehradun, Uttarakhand, India. 2. Senior Resident, Department of Orthopaedics, Himaliyan Institute of Medical Sciences, Dehradun, Uttarakhand, India. 3. Professor, Department of Orthopaedics, Himaliyan Institute of Medical Sciences, Dehradun, Uttarakhand, India.

Correspondence Address :
Chetan Peshin,
B 18-3/HIHT Complex, SRHU Campus, Doiwala, Dehradun-248016, Uttarakhand, India.
E-mail: chetanpeshin@gmail.com

Abstract

Introduction: Chronic osteomyelitis in the paediatric age group is a frequent complication of improperly treated acute haematogenous osteomyelitis, leading to devastating complications such as pathological fractures and deformities in affected children. There is a growing need to comprehend the disease process and develop improved treatment strategies.

Aim: To evaluate bacterial culture and antibiotic sensitivity patterns in children and adolescents with chronic haematogenous osteomyelitis in North India and to explore associations between radiological patterns and antibiotic sensitivity.

Materials and Methods: The present retrospective study was conducted in the Department of Orthopaedics of tertiary care centre, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, North India, from July 2018 to June 2020. Total 100 children and young adolescents with chronic osteomyelitis who reported to OPD of hospital with pus discharge from an extremity persisting for more than six weeks, along with radiological features indicative of chronic osteomyelitis. Parameters such as site of infection, illness duration, blood parameters, bacteriological culture reports, etc., were examined. Radiological evaluation was performed using the Beit CURE (BC) classification. Data were analysed and represented in the form of frequencies and percentages. The Chi-square test was used to compare proportions, with significance set at p-value <0.05.

Results: The median age of the study population was 13 years, there were 32 (32%) females and 68 (68%) males. The majority of cases (70%) belonged to the B1-B3 group. Staphylococcus aureus was responsible for 86 (86%) cases, followed by Pseudomonas aeruginosa in 7 (7%) cases. Out of the 86 Staphylococcus aureus (S. aureus) isolates, 58 (67.44%) were Methicillin-resistant Staphylococcus aureus (MRSA). Multidrug resistance was observed among gram-negative species, as well. Pseudomonas aeruginosa showed resistance to fluoroquinolones in 4 (57%) cases, aminoglycosides in 2 (28%) cases, and carbapenem in 1 (14%) case, which is considered highly effective in treating serious infections caused by multidrug resistant Gram-negative species. No significant association was found between drug sensitivity patterns and radiological features in the present study.

Conclusion: Staphylococcus aureus remains the most predominant organism isolated from deep tissue cultures. Among S. aureus isolates, MRSA was the most frequently identified. Identifying the causative organism may be challenging in some cases. Among cases where the offending microbe was identified, drug resistance was widespread among both Gram-negative and Gram-positive specimens. No significant relationship was found between the radiological appearance of infected bone and the pattern of antibiotic resistance.

Keywords

Aminoglycosides, C-reactive protein, Fluoroquinolones, Staphylococcus aureus

Chronic osteomyelitis is an inflammatory bone condition that progresses due to microorganisms, leading to bone destruction and the formation of sequestrum (1),(2). The incidence rate of this condition is 10-14 per 100,000 children annually (3),(4). But significantly higher rates of 76 per 100,000 have been reported in Maori children in New Zealand, and much lower rates of 3 per 100,000 have been reported in Scotland (5),(6). Infection sources can include a contiguous focus of infection (such as infected decubiti), remote penetrating trauma, surgery, or a late complication of acute haematogenous osteomyelitis. Chronic haematogenous osteomyelitis is a consequence of acute osteomyelitis, where inadequate management leads to residual disease that can result in disability. Its treatment requires prolonged care, multiple surgical procedures and frequent hospitalisations (7).

Chronic osteomyelitis can be a consequence of inadequately treated acute osteomyelitis and is characterised by low-grade bone infection (7),(8). This is more prevalent in third-world nations where healthcare resources are insufficient, posing risks to the health and quality of life of patients and their caregivers. Treatment for chronic osteomyelitis is often lengthy, involving multiple surgeries and extended hospital stays (8). In the paediatric population, chronic osteomyelitis is more common than in adults, and its sequelae affect children more frequently (3). Treatment typically involves an interdisciplinary approach combining systemic and/or local antibiotics with surgical-orthopaedic procedures. Procedures like sequestrectomy, radical surgical debridement, and plastic reconstructive techniques such as flap coverage, skin grafting, and negative pressure wound therapy are often necessary. The primary goal of chronic osteomyelitis management is to restore function early and eradicate the infection (9).

The most common microorganism causing chronic osteomyelitis is known to be Staphylococcus aureus, with a 60-70% frequency rate globally in both developing and developed countries (3),(4),(5). However, due to varied presentations, a more diverse microbiology is observed with chronic haematogenous osteomyelitis. Unfortunately, there is a lack of comprehensive studies to guide orthopaedic surgeons in treating this complex disease in the paediatric population (10),(11). Therefore, the present study was aimed primarily to evaluate bacterial culture and antibiotic sensitivity patterns in children and adolescents with chronic osteomyelitis and to explore associations between radiological patterns and antibiotic sensitivity among the patients.

Material and Methods

This was a retrospective review of patients visiting conducted in the Department of Orthopaedics OPD, Himalayan Institute of Medical Sciences (tertiary care institution), Dehradun, Uttarakhand, North India, from July 2018 to June 2020. The Institutional Ethics Board reviewed and approved the study (HIMS/RC/2018/204), and informed consent was obtained from participants. A total of 100 cases were included using a random convenience sampling method.

Inclusion criteria: Children and young adolescents visiting the hospital’s OPD with pus discharge from an extremity for more than six weeks, along with radiological features of chronic osteomyelitis, were included in the study.

Exclusion criteria: Patients with features of acute osteomyelitis or non haematogenous chronic osteomyelitis were excluded from the study.

Study Procedure

The patient’s demographics, clinical presentation, hospital course (duration of stay, antibiotics before admission, site of infection, surgical and medical management), blood reports {Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), C-reactive Protein (CRP)}, radiological findings {X-ray, Magnetic Resonance Imaging (MRI)}, culture report (bacterial), Beit CURE classification (12), histopathology report, antibiotics given (i.v./Oral) along with duration were noted. The Beit CURE classification is a radiological classification used to grade paediatric chronic osteomyelitis, classifiable as A, B1-B4, C and unclassifiable, with type A being mild and type C indicating the most severe involvement (Table/Fig 1).

All the patients were treated according to a fixed hospital in-patient protocol. Surgical debridement was performed, and the first deep tissue culture was taken intraoperatively. Antibiotics were stopped in all cases prior to the first surgery to improve the chances of isolating the offending microorganism, and they were started only after taking the first deep tissue culture intraoperatively. Regarding empirical antibiotic therapy, piperacillin-tazobactam (100 mg/kg piperacillin, 10 mg/kg tazobactam) was given parenterally to all patients who had not received any antibiotics before presenting. Furthermore, for patients already taking antibiotics, the same regimen were continued empirically. After the first procedure, if the patient had a discharge from the suture line or persistence of any symptoms/ signs of infection, the patient was planned for a second debridement, and a second deep tissue culture was again taken intraoperatively. Antibiotics were continued for a period of six weeks or changed, if discharge or signs of infection were present according to culture sensitivity. Antibiotic bone cement was used for patients requiring multiple debridements and for dead space management. All cases were followed for a period of one year (Table/Fig 2).

Statistical Analysis

Data analysis was done using MS Excel. All categorical data were presented in the form of frequencies and percentages. The difference between MRSA and non MRSA was observed using a Chi-square test. The p-value less than 0.05 were considered statistically significant.

Results

Out of a total of 100 patients, there were 60 (60%) children between 12 years and 18 years of age, 38 (38%) children between two years and 12 years of age, and 2 (2%) children below two years of age, while the median age was 13 years. There were 32 (32%) females and 68 (68%) males in the present study. The tibia was involved in 38 (38%) patients, the femur in 28 (28%), the humerus in 12 (12%), the radius in 4 (4%) patients, and other bones in 18 (18%) patients. The duration of illness before seeking treatment varied from less than two months in 28 (28%) cases to 2-12 months in 60 (60%) cases and more than one year in 12 cases (Table/Fig 3). The number of debridements needed before clearance (at least two subsequent negative cultures) was one in 34 cases, two in 42 cases, three in 12 cases and more than three in 12 cases.

Beit CURE (BC) classification was used on preoperative X-rays for evaluation. Most of the cases (70%) belonged to the B1-B3 group (Table/Fig 2). In this group, cases classified as B1 required the least number of surgical procedures, while B3 and B4 had to undergo the maximum number of debridements. Type C also required an equivalent number of surgical procedures as type B2 (Table/Fig 4). The first culture taken among the present study population was positive in 68 patients and negative for any growth in 32 patients. Out of these 100, 66 required a 2nd debridement due to the persistence of discharge or symptoms/signs of infection. Thus, a 2nd intraoperative deep tissue culture was taken in these 66 patients, and it was positive for 34 patients. Among the initial 32 patients that were culture negative, 10 had discharge from the suture line or symptoms and signs of infection, leading to the need for repeat debridement. Among these 10, eight patients had positive cultures, and Staphylococcus aureus was isolated in six of them (Table/Fig 5).

Based on the culture and sensitivity patterns, Staphylococcus aureus was the most predominantly identified organism. Other isolated organisms included Pseudomonas aeruginosa (P. aeruginosa), 4 (4), streptococcus, 2 (2%), acinetobacter, 2 (2%), Proteus mirabilis, 2 (2%) and enterococcus (found in three patients after the 2nd debridement). Out of the 86 S. aureus isolates, 58 (67.44%) were MRSA. Maximum resistance was observed against ciprofloxacin (72% of cases with S. aureus). Vancomycin resistance was observed in 10 cases (11.62%) with S. aureus, while all the isolates were sensitive to linezolid and teicoplanin, 86 (100) (with S. aureus). High susceptibility was observed with tetracycline, 66 (76.74%) and clindamycin, 74 (86.04%). Other Gram-positive bacteria (streptococcus and enterococcus) were sensitive to a large number of antibiotics; however, they showed 100% susceptibility to vancomycin, linezolid and teicoplanin. Pseudomonas (4 out of 7) isolates were resistant to ciprofloxacin (57.14%), while they showed good sensitivity to gentamycin, cefoperazone-sulfbactum, and imipenem (Table/Fig 6).

Furthermore, based on the difference in proportion in culture patterns with Beit CURE X-ray classification, no association was observed between the presence of MRSA and a more severe Beit CURE X-ray grade. However, the maximum number of MRSA was observed for grade B2-C, 34 (58.62%) and only 4 (6.89%) for grade A-B1 (Table/Fig 7).

Regarding the clinical outcome, 24 out of 100 required three or more debridements. Antibiotic-bone cement was used in 18 cases, 11 of which underwent bone grafting for dead space management after the subsidence of infection. Overall, 16 patients did not show clinical and radiological improvement; nine of them were multidrug-resistant, and seven underwent amputation.

Discussion

Chronic osteomyelitis is a persistent disease, difficult to treat or eradicate completely. In the absence of early diagnosis and prompt treatment, or in cases of antibiotic therapy failure due to the development of drug resistance, chronic osteomyelitis becomes an important cause of high morbidity, especially in developing countries (9).

Epidemiological data described in recent articles were validated (13),(14). In the present study, the maximum number of patients were in the age group of 12-18 years (60%), with the majority being males (68%), and involving lower limb long bones in 66% of cases (15). Children presented with raised White Blood Cells (WBC) count, ESR and CRP, with the sensitivity of ESR and CRP being higher compared to leucocytosis. The WBC count was elevated in 46% of patients with a mean value of 9.5; ESR and CRP were elevated in >90% of cases, aligning with previous literature (16). For preoperative X-ray evaluation, the Beit CURE classification was utilised. It is the only classification designed solely for chronic haematogenous osteomyelitis. It is simple, reliable, and reproducible, requiring just plain radiographs, which are widely available throughout the developing world (12). The maximum number of cases according to this classification belonged to the B3 group, while group A had the least. Previous literature supports this result (17). Type A and B1 required the least surgical input, while types B2, B3, B4 and C required a higher number of surgeries, with B4 topping the group. Thus, a correlation of the classification grade with the number of procedures required can be established, which would further aid in resource allocation and developing a strategic treatment plan (12),(17). Regarding the most common bone involved, the results reflect previous studies, with the tibia being the most commonly affected bone followed by the femur and humerus (18),(19). This is likely due to the poor soft tissue cover around the tibia, leaving the periosteum vulnerable to infection.

Despite drastic improvements and recent advances in the diagnosis and treatment of the disease, sepsis continues to be a major cause of morbidity and mortality in the paediatric population, especially in developing countries. The microbiological profile and their antibiotic susceptibility pattern show wide variations, presenting a challenging task in eliminating the infection. The appropriate treatment of chronic osteomyelitis requires a culture-directed approach (20),(21). Recent literature suggests that deep tissue or bone specimen cultures are more reliable than superficial swab cultures for identifying the correct etiological organism (21),(22). Studies by Tong SY et al., and Lobati F et al., and many others conducted in various countries, particularly in developing nations, draw a conclusion that Staphylococcus aureus causes 80-90% of cases of chronic haematogenous osteomyelitis in children (23),(24). Authors hereby found S. aureus to be responsible for 86% of cases, followed by Pseudomonas aeruginosa (7%). A large study on this subject was conducted in Malawi with 167 children suffering from chronic haematogenous osteomyelitis, in which 61.7% of the isolates were Staph aureus (25).

A large proportion of the identified S. aureus specimens were Methicillin-resistant (36.04%), while 100% sensitivity was observed with teicoplanin and linezolid. High levels of susceptibility were observed with cotrimoxazole (73.25%) and clindamycin (86.04%), which have been found to achieve high levels of bone concentration (50% with cotrimoxazole and 70-80% with clindamycin) and are as effective as vancomycin (26). Other Gram-positives, streptococcus and enterococcus showed excellent sensitivity to clindamycin, vancomycin, linezolid and teicoplanin (100%). Multidrug resistance was observed with Gram-negative species. Pseudomonas aeruginosa was resistant to fluoroquinolones in four out of seven cases and to aminoglycosides in two out of seven cases, while it even showed resistance to carbapenem in one case, which is considered the most potent in treating serious infections caused by multi-drug-resistant Gram-negative species. This is in contrast with the study by Mthethwa P and Marais L which the carbapenem group (27). Multidrug resistance was also noted with other Gram-negative bacteria isolated, such as Proteus mirabilis. Infection with multidrug-resistant MDR organisms poses a serious challenge for the clinician. Delayed empirical antibiotic therapy or inappropriate antibiotic therapy leads to the worsening of the disease, further increasing morbidity and the financial burden on the patient. The present study supports the conclusion drawn by Banerjee B et al., that piperacillin-tazobactam along with clindamycin can be an effective empirical treatment regime, which can be modified after a culture report. However, considering the high incidence of MRSA, vancomycin can also be considered in place of clindamycin (26).

Furthermore, regarding clinical outcome, the authors observed that those patients whose culture grew MDR organisms had a much more severe infection in terms of X-ray presentation, duration of hospital stay, number of debridements required and late sequelae of chronic osteomyelitis. About 58.62% of MRSA belonged to the B2-C Beit CURE group, requiring more surgical intervention and having a poorer prognosis.

Limitation(s)

Due to the retrospective nature of the study, recall bias was inevitable. The present study was conducted on a sample of 100 patients who presented to the OPD of a tertiary care hospital. Therefore, a study with a larger sample size and a prospective study design will further corroborate the results.

Conclusion

Chronic haematogenous osteomyelitis in children is not a rare disease in developing countries and causes substantial morbidity. Regarding microbiology, S. aureus is definitely the most prevalent; however, the aetiology is diverse, and the presence of multidrug-resistant organisms further complicates the treatment. An association between higher levels of drug resistance and a worse X-ray picture was postulated while designing the study, but no association was found between drug sensitivity patterns and radiological pictures among this group of patients.

Authors contribution: CP: Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Writing- review and editing. RR: Conceptualisation; Data curation; Formal analysis; Funding acquisition; Visualisation; Roles/writing- original draft. DPS: Writing and Validation. AJ: Validation and supervision.

References

1.
Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364:369-79.[crossref][PubMed]
2.
Klenerman L. A history of osteomyelitis from the Journal of Bone and Joint Surgery: 1948 to 2006. J Bone Joint Surg [Br]. 2007;89(5):667-70. [crossref][PubMed]
3.
Malcius D, Trumpulyte G, Barauskas V, Kilda A. Two decades of acute haematogenous osteomyelitis in children: Are there any changes? Paediatr Surg Int. 2005;21(5):356-59. [crossref][PubMed]
4.
Riise OR, Kirkhus E, Handeland KS, Flatø B, Reiseter T, Cvancarova M, et al. Childhood osteomyelitis-incidence and differentiation from other acute onset musculoskeletal features in a population based study. BMC Paediatr. 2008;8:45. [crossref][PubMed]
5.
Gillespie WJ. Racial and environmental factors in acute haematogenous osteomyelitis in New Zealand. N Z Med J. 1979;90(641):93-95.
6.
Blyth MJ, Kincaid R, Craigen MA, Bennet GC. The changing epidemiology of acute and subacute haematogenous osteomyelitis in children. J Bone Joint Surg Br. 2001;83(1): 99-102. [crossref][PubMed]
7.
Lazzarini L, De Lalla F, Mader JT. Long bone osteomyelitis. Curr Infect Dis Rep. 2002;4(5):439-45. [crossref][PubMed]
8.
Gentry LO. Management of osteomyelitis. Int J Antimicrob Agents. 1997;9(1):37-42.[crossref][PubMed]
9.
Liu T, Zhang X, Li Z, Peng D. Management of combine bone defects and limb-length discrepancy after tibial chronic osteomyelitis. Orthopaedics. 2011;34(8):363-67. [crossref][PubMed]
10.
Spiegel DA, Penny JN. Chronic osteomyelitis in children. Techniques in orthopaedics. 2005;20(2):142-52. [crossref]
11.
Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg. 2004;188(Suppl):57-66. [crossref][PubMed]
12.
Wynn Jones H, Bates J, Harrison WJ, Evans GA, Lubega N. Radiological classification of chronic haematogenous osteomyelitis in children. J Paediatr Orthop. 2009;29(7):822-27. [crossref][PubMed]
13.
Berbari EF, Osmon DR, Steckelberg JM, Tande AJ. Osteomyelitis. Mandell, Douglas and Bennett’s Priniciples and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier. 2020. Chap 104.
14.
Arnold JC, Bradley JS. Osteoarticular infections in children. Infect Dis Clin N Am. 2015;29:557-74. [CrossRef] [PubMed]. [crossref][PubMed]
15.
Auh JS, Binns HJ, Katz BZ. Retrospective assessment of subacute or chronic osteomyelitis in children and young adults. Clin Paediatr. 2004;43(6):549-55. [crossref][PubMed]
16.
Pääkkönen M, Kallio MJ, Kallio PE, Peltola H. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res. 2010;468(3):861-66. [crossref][PubMed]
17.
Stevenson AJ, Jones HW, Chokotho LC, Beckles VL, Harrison WJ. The Beit cure classification of childhood chronic haematogenous osteomyelitis- A guide to treatment. J Orthop Surg Res. 2015;10:144. [crossref][PubMed]
18.
Lauschke FH, Fery CT. Haematogenous osteomyelitis in infants and children in the northwestern region of Namibia. Management and two-year results. J Bone Joint Surg Am. 1994;76(4):502-10. [crossref][PubMed]
19.
Daoud A, Saighi Bouaouina A. Treatment of sequestra, pseudoarthroses, and defects in the long bones of children who have chronic haematogenous osteomyelitis. J Bone Joint Surg Am. 1989;71(10):1448-68.[crossref][PubMed]
20.
Negussie A, Mulugeta G, Bedru A, Ali I, Shimeles D, Lema T, et al. Bacteriological profile and antimicrobial susceptibility pattern of blood culture isolates among septicemia suspected children in selected hospitals Addis Ababa, Ethiopia. Int J Biol Med Res. 2015;6(1):4709-17.
21.
Zhang X, Lu Q, Liu T, Li Z, Cai W. Bacterial resistance trends among intraoperative bone culture of chronic osteomyelitis in an affiliated hospital of South China for twelve years. BMC Infectious Diseases. 2019;19:823. [crossref][PubMed]
22.
Ulug M, Ayaz C, Celen MK, Geyik MF, Hosoglu S, Necmioglu S. Are sinus track cultures reliable for identifying the causative agent in chronic osteomyelitis? Arch Orthop Trauma Surg. 2009;129(11):1565-70. [crossref][PubMed]
23.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603-61. [crossref][PubMed]
24.
Lobati F, Herndon B, Bamberger D. Osteomyelitis: Etiology, diagnosis, treatment and outcome in a public versus a private institution. Infection. 2001;29(6):333-36. [crossref][PubMed]
25.
Beckles VL, Jones HW, Harrison WJ. Chronic haematogenous osteomyelitis in children: A retrospective review of 167 patients in Malawi. J Bone Joint Surg Br. 2010;92(8);1138-43. [crossref][PubMed]
26.
Banerjee B, Bhat SS, Mukhopadhyay C, Bhat AK. Microbiological evaluation of osteomyelitis with a special reference to antibiotic sensitivity pattern of isolates from a tertiary care hospital. J Pure Appl Microbiol. 2020;14(1):485-90. [crossref]
27.
Mthethwa P, Marais L. The microbiology of chronic osteomyelitis in a developing world setting. SA Orthop. 2017;16(2):39-45.[crossref]

DOI and Others

DOI: 10.7860/JCDR/2024/64451.19359

Date of Submission: Apr 27, 2023
Date of Peer Review: Aug 01, 2023
Date of Acceptance: Jan 20, 2024
Date of Publishing: May 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? No
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 27, 2023
• Manual Googling: Jan 16, 2024
• iThenticate Software: Jan 18, 2024 (3%)

ETYMOLOGY: Author Origin

EMENDATIONS: 8

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com